AAAAAA

   
Results: 1-25 |
Results: 25

Authors: Russo, P Ottoboni, C Crippa, A Riou, JF O'Connor, PM
Citation: P. Russo et al., RPR-115135, a new non peptidomimetic farnesyltransferase inhibitor, induces G(0)/G(1) arrest only in serum starved cells, INT J ONCOL, 18(4), 2001, pp. 855-862

Authors: Karayan, L Riou, JF Seite, P Migeon, J Cantereau, A Larsen, CJ
Citation: L. Karayan et al., Human ARF protein interacts with Topoisomerase I and stimulates its activity, ONCOGENE, 20(7), 2001, pp. 836-848

Authors: Pascal, A Riou, JF Carron, C Boucaut, JC Umbhauer, M
Citation: A. Pascal et al., Cloning and developmental expression of STAT5 in Xenopus laevis, MECH DEVEL, 106(1-2), 2001, pp. 171-174

Authors: Guittat, L Alberti, P Mergny, JL Riou, JF Teulade-Fichou, MP Mailliet, P
Citation: L. Guittat et al., Telomerase inhibitors: possible consequences in cancer therapy, M S-MED SCI, 17(10), 2001, pp. 1076-1081

Authors: Koeppel, F Riou, JF Laoui, A Mailliet, P Arimondo, PB Labit, D Petitgenet, O Helene, C Mergny, JL
Citation: F. Koeppel et al., Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes, NUCL ACID R, 29(5), 2001, pp. 1087-1096

Authors: Tamburlin-Thumin, I Crozet, MP Barriere, JC Barreau, M Riou, JF Lavelle, F
Citation: I. Tamburlin-thumin et al., Synthesis and biological evaluation of O-alkylated tropolones and related alpha-ketohydroxy derivatives as ribonucleotide reductase inhibitors, EUR J MED C, 36(6), 2001, pp. 561-568

Authors: Mergny, JL Lacroix, L Teulade-Fichou, MP Hounsou, C Guittat, L Hoarau, M Arimondo, PB Vigneron, JP Lehn, JM Riou, JF Garestier, T Helene, C
Citation: Jl. Mergny et al., Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay, P NAS US, 98(6), 2001, pp. 3062-3067

Authors: Pilch, B Allemand, E Facompre, M Bailly, C Riou, JF Soret, J Tazi, J
Citation: B. Pilch et al., Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506, CANCER RES, 61(18), 2001, pp. 6876-6884

Authors: Mailliet, P Laoui, A Bourzat, JD Capet, M Cheve, M Commercon, A Dereu, N LeBrun, A Martin, JP Peyronel, JF Salagnad, C Thompson, F Zucco, M Guitton, JD Pantel, G Bissery, MC Brealey, C Lavayre, J Lelievre, Y Riou, JF Vrignaud, P Duchesne, M Lavelle, F
Citation: P. Mailliet et al., From random screening of chemical libraries to the optimization of FPP-Competitive inhibitors of farnesyltransferase, CANC DRUG, 8, 2001, pp. 115-144

Authors: Lavelle, F Riou, JF Laoui, A Mailliet, P
Citation: F. Lavelle et al., Telomerase: a therapeutic target for the third millennium?, CR R ONC H, 34(2), 2000, pp. 111-126

Authors: Djiane, A Riou, JF Umbhauer, M Boucaut, JC Shi, DL
Citation: A. Djiane et al., Role of frizzled 7 in the regulation of convergent extension movements during gastrulation in Xenopus laevis, DEVELOPMENT, 127(14), 2000, pp. 3091-3100

Authors: Barbier, C Joissains, A Commercon, A Riou, JF Huet, F
Citation: C. Barbier et al., Preparation of lavendamycin analogues, HETEROCYCLE, 53(1), 2000, pp. 37-48

Authors: Arimondo, PB Riou, JF Mergny, JL Tazi, J Sun, JS Garestier, T Helene, C
Citation: Pb. Arimondo et al., Interaction of human DNA topoisomerase I with G-quartet structures, NUCL ACID R, 28(24), 2000, pp. 4832-4838

Authors: Umbhauer, M Djiane, A Goisset, C Penzo-Mendez, A Riou, JF Boucaut, JC Shi, DL
Citation: M. Umbhauer et al., The C-terminal cytoplasmic Lys-Thr-X-X-X-Trp motif in frizzled receptors mediates Wnt/beta-catenin signalling, EMBO J, 19(18), 2000, pp. 4944-4954

Authors: Giraud, E Luttmann, C Lavelle, F Riou, JF Mailliet, P Laoui, A
Citation: E. Giraud et al., Multivariate data analysis using D-optimal designs, partial least squares,and response surface modeling: A directional approach for the analysis of farnesyltransferase inhibitors, J MED CHEM, 43(9), 2000, pp. 1807-1816

Authors: Umbhauer, M Penzo-Mendez, A Clavilier, L Boucaut, JC Riou, JF
Citation: M. Umbhauer et al., Signaling specificities of fibroblast growth factor receptors in early Xenopus embryo, J CELL SCI, 113(16), 2000, pp. 2865-2875

Authors: Wu, L Davies, SL North, PS Goulaouic, H Riou, JF Turley, H Gatter, KC Hickson, ID
Citation: L. Wu et al., The Bloom's syndrome gene product interacts with topoisomerase III, J BIOL CHEM, 275(13), 2000, pp. 9636-9644

Authors: Goossens, JF Henichart, JP Anizon, F Prudhomme, M Dugave, C Riou, JF Bailly, C
Citation: Jf. Goossens et al., Cellular uptake and interaction with purified membranes of rebeccamycin derivatives, EUR J PHARM, 389(2-3), 2000, pp. 141-146

Authors: Goulaouic, H Roulon, T Flamand, O Grondard, L Lavelle, F Riou, JF
Citation: H. Goulaouic et al., Purification and characterization of human DNA topoisomerase III alpha, NUCL ACID R, 27(12), 1999, pp. 2443-2450

Authors: Mergny, JL Mailliet, P Lavelle, F Riou, JF Laoui, A Helene, C
Citation: Jl. Mergny et al., The development of telomerase inhibitors: the G-quartet approach, ANTI-CAN DR, 14(4), 1999, pp. 327-339

Authors: Bailly, C Qu, XG Anizon, F Prudhomme, M Riou, JF Chaires, JB
Citation: C. Bailly et al., Enhanced binding to DNA and topoisomerase I inhibition by an analog of theantitumor antibiotic rebeccamycin containing an amino sugar residue, MOLEC PHARM, 55(2), 1999, pp. 377-385

Authors: Moreau, P Anizon, F Sancelme, M Prudhomme, M Bailly, C Severe, D Riou, JF Fabbro, D Meyer, T Aubertin, AM
Citation: P. Moreau et al., Syntheses and biological activities of rebeccamycin analogues. Introduction of a halogenoacetyl substituent, J MED CHEM, 42(4), 1999, pp. 584-592

Authors: Moreau, P Anizon, F Sancelme, M Prudhomme, M Severe, D Riou, JF Goossens, JF Henichart, JP Bailly, C Labourier, E Tazzi, J Fabbro, D Meyer, T Aubertin, AM
Citation: P. Moreau et al., Synthesis, mode of action, and biological activities of rebeccamycin bromoderivatives, J MED CHEM, 42(10), 1999, pp. 1816-1822

Authors: Labourier, E Riou, JF Prudhomme, M Carrasco, C Bailly, C Tazi, J
Citation: E. Labourier et al., Poisoning of topoisomerase I by an antitumor indolocarbazole drug: Stabilization of topoisomerase I-DNA covalent complexes and specific inhibition ofthe protein kinase activity, CANCER RES, 59(1), 1999, pp. 52-55

Authors: Riou, JF Delarue, M Mendez, AP Boucaut, JC
Citation: Jf. Riou et al., Role of fibroblast growth factor during early midbrain development in Xenopus, MECH DEVEL, 78(1-2), 1998, pp. 3-15
Risultati: 1-25 |